| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.1A>G | p.Met1? | Heterozygous | CAUSAL |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| ATG | Met | GTG | Val | A->G | Ts |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| Ju, NM, RP | No | No |
| At the mRNA level | On restriction map |
| New restriction site(s): none Lost restriction site(s): none |
| Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
|---|---|---|
| 0 | - | 100 (Pathogenous) |
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of Death | Geographic origin |
| 02-FA21-G05O- | Proband | Male | 53 |
| Phenotypic group | Disease |
| Please contact curator |
| Reference ID | PubMed ID | Reference |
| 15 | 15714081 | Klein, R. D., Salih, S., Bessoni, J., & Bale, A. E. (2005). Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genetics in Medicine?: Official Journal of the American College of Medical Genetics, 7(2), 131?8. doi:10.109701.GIM.0000153663.62300.F8 |